DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Peoria, AZ

9 verified pulmonary disease doctors in Peoria.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Arizona Medical Board

Dr. Abdullah Yonan, MD

Pulmonary Disease

21 yrs NPPES
NPI 1255324182
9171 W THUNDERBIRD RD, SUITE 101, Peoria, AZ 85381(623) 815-7800
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,031 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,031

Total received

49

Transactions

15

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$299.60
Genzyme Corporation$183.66
Boehringer Ingelheim Pharmaceuticals, Inc.$147.44
AstraZeneca Pharmaceuticals LP$146.49
Electromed, Inc.$47.53
Harmony Biosciences LLC$34.85

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 80th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Abdullah Yonan do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Girish Mehta, MD

Pulmonary Disease

21 yrs NPPES
NPI 1508854787
13634 NORTH 93RD AVENUE, SUITE 100, Peoria, AZ 85381(623) 933-0301
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,699 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,699

Total received

85

Transactions

24

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$392.36
Boehringer Ingelheim Pharmaceuticals, Inc.$214.69
United Therapeutics Corporation$182.99
Actelion Pharmaceuticals US, Inc.$103.52
Mylan Specialty L.P.$98.02
Genentech USA, Inc.$84.19

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Girish Mehta do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Avtar Bassin, MD

Pulmonary Disease

21 yrs NPPES
NPI 1013998335
13352 N 83RD AVE, SUITE #A 100, Peoria, AZ 85381(623) 977-8871
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Amit Dhingra, MD

Pulmonary Disease

20 yrs NPPES
NPI 1437122397
13634 N 93RD AVE STE 100, Peoria, AZ 85381(623) 933-0301
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,320 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,320

Total received

63

Transactions

16

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$210.63
Boehringer Ingelheim Pharmaceuticals, Inc.$190.83
Regeneron Healthcare Solutions, Inc.$160.73
Genentech USA, Inc.$108.58
Genzyme Corporation$105.82
Grifols USA, LLC$97.60

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 82th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Amit Dhingra do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Walter Migotto, MD

Pulmonary Disease

20 yrs NPPES
NPI 1922013689
9171 W THUNDERBIRD RD, SUITE 101, Peoria, AZ 85381(623) 815-7800
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Shahid Yakoob, MD

Pulmonary Disease

20 yrs NPPES
NPI 1386656049
13634 N 93RD AVE, #100, Peoria, AZ 85381(623) 933-0301
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,985 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,985

Total received

98

Transactions

26

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$399.90
Boehringer Ingelheim Pharmaceuticals, Inc.$284.07
United Therapeutics Corporation$183.01
AstraZeneca Pharmaceuticals LP$139.01
Actelion Pharmaceuticals US, Inc.$105.48
Genzyme Corporation$103.16

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Shahid Yakoob do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Thomas Pollard, DO

Pulmonary Disease

20 yrs NPPES
NPI 1710069885
13634 N 93RD AVE STE 100, Peoria, AZ 85381(623) 933-0301
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $4,118 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$4,118

Total received

107

Transactions

24

Paying companies

Top paying companies

Genzyme Corporation$1,560
GlaxoSmithKline, LLC.$1,147
Boehringer Ingelheim Pharmaceuticals, Inc.$221.47
AstraZeneca Pharmaceuticals LP$182.39
United Therapeutics Corporation$157.60
Actelion Pharmaceuticals US, Inc.$117.22

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Thomas Pollard do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jack Tuber, DO

Pulmonary Disease

20 yrs NPPES
NPI 1306923750
6818 W THUNDERBIRD RD, Peoria, AZ 85381(623) 566-3550
NPPES public registry
CMS Open Payments· $3,637 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$3,637

Total received

138

Transactions

23

Paying companies

Top paying companies

UCB, Inc.$774.75
AbbVie Inc.$762.10
Amgen Inc.$720.30
Janssen Biotech, Inc.$273.16
GlaxoSmithKline, LLC.$186.32
Mallinckrodt Hospital Products Inc.$161.50

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jack Tuber do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Gagandip Singh, MD

Pulmonary Disease

16 yrs NPPES
NPI 1801127568
13634 N 93RD AVE STE 100, Peoria, AZ 85381(239) 330-3016
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,364 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,364

Total received

108

Transactions

27

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$405.67
Boehringer Ingelheim Pharmaceuticals, Inc.$328.14
Penumbra, Inc.$199.70
AstraZeneca Pharmaceuticals LP$192.87
United Therapeutics Corporation$165.24
Actelion Pharmaceuticals US, Inc.$165.13

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 87th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Gagandip Singh do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Peoria, AZ — Verified | DoctorsProof | DoctorsProof